RMgmDB - Rodent Malaria genetically modified Parasites

Back to search results

Summary

RMgm-4165
Malaria parasiteP. berghei
Genotype
DisruptedGene model (rodent): PBANKA_0605800; Gene model (P.falciparum): PF3D7_1207300; Gene product: LIMP protein, putative (LIMP)
Transgene
Transgene not Plasmodium: RFP
Promoter: Gene model: PBANKA_1319500; Gene model (P.falciparum): PF3D7_1455800; Gene product: LCCL domain-containing protein (LAP4; LCCL/lectin adhesive-like protein 4; CCp2)
3'UTR: Gene model: PBANKA_1359600; Gene product: transmission blocking target antigen precursor 6-cysteine protein (P48/45)
Replacement locus: Gene model: PBANKA_0306000; Gene product: 6-cysteine protein (230p)
Transgene
Transgene not Plasmodium: GFP (gfp-mut3)
Promoter: Gene model: PBANKA_0416100; Gene model (P.falciparum): PF3D7_0905300; Gene product: dynein heavy chain, putative
3'UTR: Gene model: PBANKA_1010600; Gene product: calmodulin, putative (cam)
Replacement locus: Gene model: PBANKA_0306000; Gene product: 6-cysteine protein (230p)
Phenotype Oocyst; Sporozoite; Liver stage;
Last modified: 28 December 2020, 13:58
  *RMgm-4165
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene disruption, Introduction of a transgene, Introduction of a transgene
Reference (PubMed-PMID number) Reference 1 (PMID number) : 28525314
Reference 2 (PMID number) : 33347893
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone P. berghei ANKA 820cl1m1cl1 (RMgm-164)
Other information parent lineP. berghei ANKA 820cl1m1cl1 (RMgm-164) is a reference ANKA mutant line which expresses GFP under control of a male and RFP under control of a female gametocyte specific promoter. This reference line does not contain a drug-selectable marker (PubMed: PMID: 19438517).
The mutant parasite was generated by
Name PI/ResearcherSantos JM, Janse CJ, Mair GR
Name Group/DepartmentParasitology, Department of Infectious Diseases
Name InstituteUniversity of Heidelberg Medical School
CityHeidelberg
CountryGermany
Name of the mutant parasite
RMgm numberRMgm-4165
Principal nameΔlimp-a; Δlimp-b
Alternative name2091cl2m5; 2090cl2m6
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNot different from wild type
OocystNormal ookinete production/numbers. Oocyst numbers per mosquito were reduced below 50%. The number of oocyst-derived midgut sporozoites per oocyst remained unchanged; ookinete development and oocyst sporulation therefore do not require LIMP. Δlimp sporozoites did not significantly accumulate in the haemolymph, but showed a 10-fold reduction in salivary gland invasion.
SporozoiteNormal ookinete production/numbers. Oocyst numbers per mosquito were reduced below 50%. The number of oocyst-derived midgut sporozoites per oocyst remained unchanged; ookinete development and oocyst sporulation therefore do not require LIMP. Δlimp sporozoites did not significantly accumulate in the haemolymph, but showed a 10-fold reduction in salivary gland invasion.
Liver stageΔlimp sporozoites did not significantly accumulate in the haemolymph, but showed a 10-fold reduction in salivary gland invasion. Δlimp salivary gland sporozoites did not establish exoerythrocytic forms (EEFs) inside Huh7 hepatoma cells and were not infectious to mice.
Additional remarks phenotype

Mutant/mutation
The mutant lacks expression of LIMP and expresses GFP under control of a male and RFP under control of a female gametocyte specific promoter.

Protein (function)
The gene comprises six exons and five introns (this organisation is conserved throughout the genus) and encodes a protein of 110 amino acids (aa) with a 22 aa long signal peptide and a molecular weight of 13 kDa. Ab initio protein structure predictions  indicate that LIMP (I23 to G110) consists of three beta sheets opposed to two a-helices. LIMP is highly conserved among the various Plasmodium species; similarly short proteins are present in related api-complexan parasites, where the homology is focused on a 22 amino acid proline-rich region adjacent to the signal peptide.

Phenotype
Normal ookinete production/numbers. Oocyst numbers per mosquito) were reduced below 50%. The number of oocyst-derived midgut sporozoites per oocyst remained unchanged; ookinete development and oocyst sporulation therefore do not require LIMP. Δlimp sporozoites did not significantly accumulate in the haemolymph, but showed a 10-fold reduction in salivary gland invasion. Δlimp salivary gland sporozoites did not establish exoerythrocytic forms (EEFs) inside Huh7 hepatoma cells and were not infectious to mice.
These results indicate a role for LIMP during mosquito midgut colonisation by the ookinete, and a crucial function for the protein during salivary gland invasion, but not for development; neither ookinete nor sporozoite formation were affected by the absence of LIMP.

In addition evidence is presented for the following:
- Δlimp sporozoites are impaired in hepatocyte transmigration, adhesion and invasion and do not glide
- Transmission electron microscopy (TEM) studies of Δlimp sporozoites revealed no ultrastructural defects in key components of the gliding motility machinery. The arrangement of the plasma membrane (PM), inner membrane complex (IMC), sub-
pellicular microtubules as well as secretory vesicles (micronemes and rhoptries) was unchanged

Additional information
The analyses a GFP-tagged version of LIMP (RMgm-4166) showed the following:
'To assess experimentally when limp is translated, we tagged the endogenous gene at the C terminus with GFP, thus leaving the fusion under the transcriptional control of the native promoter. In this mutant, limp::gfp is the only source for LIMP. We found no protein expression in asexual stage parasites or gametocytes; limp::gfp is translated in the ookinete stage and its expression is visible in crystalloids (transient and putative storage organelles of the ookinete) and the surface; the protein produced a faint ‘dusting’ on the surface of midgut and salivary gland sporozoites. In agreement with previously published results limp mRNA was not detected in asexual blood stages; mRNA is however present in gametocytes (while protein is not) and in ookinetes (where protein is present); this is consistent with limp being translationally repressed and maternally provided to the developing ookinete. Western blot analysis of ookinete material confirmed expression of a GFP fusion protein of the expected size. Parasites expressing LIMP::GFP showed no defects in liver stage development in vitro nor during transmission to the rodent host by mosquito bite'.
GFP tagging of LIMP caused a limping defect during movement with reduced speed and transient curvature changes of the parasite.

Additional information from Egarter et al 2020 (PMID: 33347893):
We observed no translation of limp in sexual precursor cells (gametocytes), despite the transcript being readily detected by RT-PCR in this life cycle stage. Using parasite clones expressing GFP-tagged translational repressors DOZI (a homolog of yeast DHH1 DEAD- box RNA helicase) and CITH (a homolog of yeast repressor of translation initiation protein SCD6), we identified limp mRNA to be associated with both proteins by RNA- immunoprecipitation (RIP) followed by RT-PCR detection of the bound transcript.

The decrease of oocyst production (50%) could result from defects in ookinete development, motility, adhesion or invasion, but the underlying cause is not clear. In order to test whether their motility was affected, we performed in vitro ookinete cultures from gametocyte-infected blood. Knock-out parasites produced apparently normal ookinetes as evaluated by differential interference contrast (DIC) microscopy ; they showed no defect in gliding motility. We next tested the ability of in vitro-cultured ookinetes to infect the mosquito vector in a controlled standard membrane feeding assay (SMFA). The gene deletion mutant reproduced the 50 % reduction in oocyst numbers. To characterize the knock-out’s failure to produce high oocyst numbers in more detail, we finally quantified ookinetes in the blood meal after 24 h of four independent SMFA. Therefore, midguts from infected mosquitoes were collected in RPMI and the blood meal isolated; the number of retained ookinetes was quantified via haemocytometer. We found the reduction in oocyst numbers to correlate with an accumulation of ookinetes in the mosquito blood meal bolus. On average, we observed  an 82% increase in retained knock-out ookinetes when compared to the wildtype controls, indicating a role for LIMP in attachment/traversal/invasion of the mosquito midgut by the ookinete.  
In conclusion limp-depleted zygotes develop into motile ookinetes with apparent normal morphology, and yet display a defect in escaping the mosquito blood meal and reaching the midgut basal lamina where they can transform into the sporozoite-producing oocyst stage

Other mutants
See PF3D7_1207300
 


  Disrupted: Mutant parasite with a disrupted gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_0605800
Gene Model P. falciparum ortholog PF3D7_1207300
Gene productLIMP protein, putative
Gene product: Alternative nameLIMP
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct used(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Partial or complete disruption of the geneComplete
Additional remarks partial/complete disruption
Selectable marker used to select the mutant parasitetgdhfr
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modification
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene nameRFP
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr/yfcu
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedure5-fluorocytosine (5-FC)
Additional remarks genetic modification
Additional remarks selection procedure
Other details transgene
Promoter
Gene Model of Parasite PBANKA_1319500
Gene Model P. falciparum ortholog PF3D7_1455800
Gene productLCCL domain-containing protein
Gene product: Alternative nameLAP4; LCCL/lectin adhesive-like protein 4; CCp2
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite PBANKA_1359600
Gene producttransmission blocking target antigen precursor 6-cysteine protein
Gene product: Alternative nameP48/45
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionReplacement locus
Gene Model of Parasite PBANKA_0306000
Gene product6-cysteine protein
Gene product: Alternative name230p
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene nameGFP (gfp-mut3)
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr/yfcu
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedure5-fluorocytosine (5-FC)
Additional remarks genetic modification
Additional remarks selection procedure
Other details transgene
Promoter
Gene Model of Parasite PBANKA_0416100
Gene Model P. falciparum ortholog PF3D7_0905300
Gene productdynein heavy chain, putative
Gene product: Alternative name
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite PBANKA_1010600
Gene productcalmodulin, putative
Gene product: Alternative namecam
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionReplacement locus
Gene Model of Parasite PBANKA_0306000
Gene product6-cysteine protein
Gene product: Alternative name230p
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4